Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.8B | 10.1B | 9.3B | 11.2B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 151M | 147M | 184M | 206M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 0 | 0 | 46M | 0 |
| Pretax income | 2.0B | 1.5B | 1.0B | 2.1B |
| Tax provision | 504M | 373M | 247M | 523M |
| Net income | 1.5B | 1.1B | 714M | 1.6B |
| Basic EPS | — | 1.8 | — | — |
| Diluted EPS | — | 1.8 | — | — |
| Basic average shares | — | 609.7M | — | — |
| Diluted average shares | — | 609.9M | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |